Company / Tangible Book Value per Share
Theravance Biopharma, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.00
FY2025
5-year range
-$5.26 / $6.00
FY2021-FY2025
Trend
+64.3%
vs FY2024
Sector context
#90 of 209
Health Care
What the data says
At $6.00, Theravance Biopharma, Inc.'s tangible book value per share ranks #90 of 209 in the Health Care sector. Tangible Book Value per Share has increased for 5 consecutive years, from $-5.33 in FY2020 to $6.00 in FY2025.
Based on SEC 10-K filings.
6.00 in FY2025.
Improved from $3.27 to $6.00 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 209 in Health CareTop 43% of 209This company $6.00 Sector average $93.47
▼
-93.6% below sector average
Key checks
Key Insights
- Theravance Biopharma, Inc.'s tangible book value per share has grown for 5 consecutive years.
- In FY2025, tangible book value per share increased 64.3% year-over-year.
- Ranks #90 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.00 | +64.3% |
| FY2024 | $3.65 | +11.8% |
| FY2023 | $3.27 | +171.8% |
| FY2022 | -$4.55 | +13.6% |
| FY2021 | -$5.26 | +1.2% |
| FY2020 | -$5.33 | -357.6% |
| FY2019 | $2.07 | -67.9% |
| FY2018 | $6.44 | +195.4% |
| FY2017 | $2.18 | -76.4% |
| FY2016 | $9.22 | +1844.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026